Belobrajdic Damien P, Jobling Stephen A, Morell Matthew K, Taketa Shin, Bird Anthony R
Commonwealth Scientific & Industrial Research Organisation (CSIRO) Food and Nutrition Flagship, Australia.
CSIRO Agriculture Flagship, Canberra, Australia, 2601.
Nutr Res. 2015 Feb;35(2):162-8. doi: 10.1016/j.nutres.2014.12.006. Epub 2014 Dec 31.
Fermentation of oat and barley β-glucans is believed to mediate in part their metabolic health benefits, but the exact mechanisms remain unclear. In this study, we sought to test the hypothesis that barley β-glucan fermentation raises circulating incretin hormone levels and improves glucose control, independent of other grain components. Male Sprague-Dawley rats (n = 30) were fed a high-fat diet for 6 weeks and then randomly allocated to 1 of 3 dietary treatments for 2 weeks. The low- (LBG, 0% β-glucan) and high- (HBG, 3% β-glucan) β-glucan diets contained 25% wholegrain barley and similar levels of insoluble dietary fiber, available carbohydrate, and energy. A low-fiber diet (basal) was included for comparison. Immediately prior to the dietary intervention, gastric emptying rate (using the (13)C-octanoic breath test) and postprandial glycemic response of each diet were determined. At the end of the study, circulating gut hormone levels were determined; and a glucose tolerance test was performed. The rats were then killed, and indices of cecal fermentation were assessed. Diet did not affect live weight; however, the HBG diet, compared to basal and LBG, reduced food intake, tended to slow gastric emptying, increased cecal digesta mass and individual and total short-chain fatty acid pools, and lowered digesta pH. In contrast, circulating levels of glucose, insulin, gastric-inhibitory peptide, and glucagon-like peptide-1, and glucose tolerance were unaffected by diet. In conclusion, wholegrain barley β-glucan suppressed feed intake and increased cecal fermentation but did not improve postprandial glucose control or insulin sensitivity.
燕麦和大麦β-葡聚糖的发酵被认为在一定程度上介导了它们对代谢健康的益处,但其确切机制仍不清楚。在本研究中,我们试图验证这样一个假设,即大麦β-葡聚糖发酵可提高循环中肠促胰岛素激素水平并改善血糖控制,且独立于其他谷物成分。将雄性Sprague-Dawley大鼠(n = 30)给予高脂饮食6周,然后随机分配至3种饮食处理之一,持续2周。低β-葡聚糖(LBG,0%β-葡聚糖)和高β-葡聚糖(HBG,3%β-葡聚糖)饮食含有25%的全谷物大麦以及相似水平的不溶性膳食纤维、可利用碳水化合物和能量。纳入低纤维饮食(基础饮食)作为对照。在饮食干预前,使用(13)C-辛酸呼气试验测定每种饮食的胃排空率和餐后血糖反应。在研究结束时,测定循环中的肠道激素水平,并进行葡萄糖耐量试验。然后处死大鼠,评估盲肠发酵指标。饮食不影响体重;然而,与基础饮食和LBG相比,HBG饮食减少了食物摄入量,倾向于减缓胃排空,增加盲肠消化物质量以及个体和总短链脂肪酸池,并降低消化物pH值。相比之下,饮食对葡萄糖、胰岛素、胃抑制肽和胰高血糖素样肽-1的循环水平以及葡萄糖耐量没有影响。总之,全谷物大麦β-葡聚糖抑制了采食量并增加了盲肠发酵,但并未改善餐后血糖控制或胰岛素敏感性。